A shadow market for unapproved slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Drug Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also receiving discount codes.
Active Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with numerous of members share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before redirecting customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, doctors and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.
Some professionals said the demand for retatrutide could be connected to the rising price of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Removal
Based on TikTok, the platform has removed problematic content and banned associated keywords and search suggestions. The company said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Digital Trading Activities
Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, positive reviews and step-by-step instructions for mixing or injecting at home.
After minutes of joining one community, a vendor shared contact information, where the majority of purchases take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, health issues or past usage.
Product Details and Costs
Within these communities, posts display dark colored packages with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for the messaging service stated it actively monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has previously seen patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to potentially significant medical dangers”.
